• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Cardiovascular risks differences in women: how can we improve the management?].

作者信息

Mounier-Vehier Claire, Delsart Pascal, Letombe Brigitte

机构信息

Service de médecine vasculaire et HTA, Pôle de cardiologie et des maladies vasculaires, Université de Lille 2 - Faculté de médecine Henri Warembourg, CHRU, F-59037 Lille Cedex, France.

出版信息

Presse Med. 2010 Feb;39(2):234-41. doi: 10.1016/j.lpm.2009.10.013. Epub 2010 Jan 13.

DOI:10.1016/j.lpm.2009.10.013
PMID:20074904
Abstract

Some aspects of cardiovascular risk differ in women; on the whole, this risk is underestimated and insufficiently treated because of lack of knowledge of the problem. According to an INSERM report in 1999, one Frenchwoman in three will die from a cardiovascular disease, while only one in 25 will die of breast cancer. For new generations of women, the protective effect of the estrogen burden may be counterbalanced by the increasing prevalence during the perimenopausal period of metabolic syndrome, particularly harmful in terms of cardiovascular risk. Before oral contraceptives are prescribed, an extremely thorough history must be taken. These should in no case be prescribed for smokers older than 35 years, regardless of how little they smoke. Neither uncomplicated diabetes nor controlled dyslipidemia is a contraindication to hormonal contraception for women. It now seems clear that hormone therapy of menopause does not prevent cardiovascular disease. Nor, however, does it increase the risk if it is administered early, that is, during the first five years of menopause, and accompanied by close monitoring of cardiovascular risk factors and annual reassessment of the benefit-risk balance. The old cliché remains true: the patient at high risk of cardiovascular disease is a man older than 50 years, who smokes and is obese. But men still die more often from cancer than from cardiovascular disease, while the latter is the leading of cause in women, especially after menopause. The symptoms are often misleading and diagnosis is thus frequently delayed. Smoking, lack of exercise, overweight, and stress are all risk factors in women of all ages, and exposure to them can increase as women grow older. These factors should alert the physician and induce earlier screening for cardiovascular disease. In practice, too many women and their physicians underestimate their real risk of cardiovascular accident. It is accordingly essential to develop new campaigns of information and prevention specifically for women.

摘要

相似文献

1
[Cardiovascular risks differences in women: how can we improve the management?].
Presse Med. 2010 Feb;39(2):234-41. doi: 10.1016/j.lpm.2009.10.013. Epub 2010 Jan 13.
2
[Heart, arteries and women, a care pathway for women at high cardiovascular risk].[心脏、动脉与女性,心血管高危女性的护理路径]
Ann Cardiol Angeiol (Paris). 2014 Jun;63(3):192-6. doi: 10.1016/j.ancard.2014.05.001. Epub 2014 Jun 2.
3
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.醋酸甲羟孕酮对雌激素依赖性风险和益处的影响——解读女性健康倡议结果的尝试。
Gynecol Endocrinol. 2006 Jun;22(6):303-17. doi: 10.1080/09513590600717368.
4
Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.口服避孕药与绝经激素治疗:心血管疾病、癌症及其他健康结局的相对风险和归因风险
Ann Epidemiol. 2015 Mar;25(3):193-200. doi: 10.1016/j.annepidem.2014.11.004. Epub 2014 Nov 13.
5
Where do we currently stand with advice on hormone replacement therapy for women?目前关于女性激素替代疗法的建议处于什么阶段?
Methodist Debakey Cardiovasc J. 2010;6(4):21-5. doi: 10.14797/mdcj-6-4-21.
6
Prevention of diseases after menopause.绝经后疾病的预防。
Climacteric. 2014 Oct;17(5):540-56. doi: 10.3109/13697137.2014.933411. Epub 2014 Jun 27.
7
Hormones and cardiovascular health in women.女性体内的激素与心血管健康
Hum Reprod Update. 2006 Sep-Oct;12(5):483-97. doi: 10.1093/humupd/dml028. Epub 2006 Jun 28.
8
Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.围绝经期女性心血管风险的管理:欧洲心脏病专家和妇科专家的共识声明
Climacteric. 2007 Dec;10(6):508-26. doi: 10.1080/13697130701755213.
9
[Cardiovascular risk of smoking by gender].按性别划分的吸烟心血管风险
Presse Med. 2017 Jul-Aug;46(7-8 Pt 1):681-687. doi: 10.1016/j.lpm.2017.05.026. Epub 2017 Jun 12.
10
Menopause and stroke and the effects of hormonal therapy.绝经、中风与激素疗法的影响
Climacteric. 2007 Oct;10 Suppl 2:27-31. doi: 10.1080/13697130701550903.

引用本文的文献

1
Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study.结直肠癌患者在治疗和生存方面是否存在性别差异?一项瑞士队列研究。
J Cancer Res Clin Oncol. 2021 May;147(5):1407-1419. doi: 10.1007/s00432-021-03557-y. Epub 2021 Mar 4.